Serum biomarkers associated with liver fibrosis in patients with type 2 diabetes

Serum biomarkers associated with liver fibrosis in patients with type 2 diabetes

BACKGROUND: The diagnosis of liver fibrosis is an important task in the management of patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. The currently used diagnostic methods have a number of disadvantages such as invasiveness and high cost, or insufficient sensitivity and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Y. A. Krasner, V. V. Romanov, O. N. Fazullina, M. F. Osipenko, V. V. Klimontov
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2024-03-01
Series:	Сахарный диабет
Subjects:	type 2 diabetes non-alcoholic fatty liver disease liver fibrosis biomarker liver elastography
Online Access:	https://www.dia-endojournals.ru/jour/article/view/13059
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Non-invasive fibrosis markers and elastography in diagnosis of fibrosis severity in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
by: O. V. Zemlianitsyna, et al.
Published: (2020-02-01)

Predicting Fibrosis Stage in MASH: The Role of Total Metabolic Syndrome Score and MMP-1
by: Bahadır Köylü, et al.
Published: (2025-06-01)

Effect of bariatric endoscopy on liver fibrosis and steatosis and the course of NAFLD – a prospective interventional study
by: Adam Vašura, et al.
Published: (2025-01-01)

Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease
by: Yang Wang, et al.
Published: (2024-04-01)

Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
by: V. P. Kovyazina, et al.
Published: (2021-04-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)

Non-Alcoholic Fatty Liver Disease and the Risk of Liver Fibrosis in Chronic Hepatitis B Patients
by: Andri Sanityoso Sulaiman, et al.
Published: (2023-09-01)

Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)

Use of liver steatosis and fibrosis indices in overweight and obese patients with or without carbohydrate metabolism disorders
by: N. N. Musina, et al.
Published: (2025-05-01)

Serum β-klotho is a potential biomarker for diagnosing alcoholic liver disease and differentiating from nonalcoholic fatty liver disease
by: Chengmei Fang, et al.
Published: (2025-08-01)

Non-invasive detection of fibrosis in non-alcoholic fatty liver disease by serum microfibrillar-associated protein 4 and its correlation with FIB-4 and transient elastography
by: Heba Abdel Rahman Eltony, et al.
Published: (2025-07-01)

Unraveling the Association of Liver Steatosis and Fibrosis with Vitamin B12: A Cross-Sectional Study
by: Silvia Espina, et al.
Published: (2024-11-01)

Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease
by: Youwen Tan, et al.
Published: (2024-12-01)

Comparison of Transient Elastography and Liver Biopsy in Assessing Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Gaurav Bachhav, et al.
Published: (2021-05-01)

Steatotic liver disease: radiological and ultrasound point of view
by: Alexey V. Borsukov, et al.
Published: (2025-01-01)

Features of cellular immunity and regeneration for alcoholic fibrosis of the liver
by: N. D. Gazatova, et al.
Published: (2019-05-01)

Correspondence to editorial on “Optimal cutoffs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”
by: Jung Hwan Yu, et al.
Published: (2025-01-01)

Inflammatory markers as predictors of liver fibrosis in type 2 diabetes patients with metabolic dysfunction-associated fatty liver disease
by: Yange Tang, et al.
Published: (2025-04-01)

Non-invasive liver fibrosis markers are increased in obese individuals with non-alcoholic fatty liver disease and the metabolic syndrome
by: Anders Askeland, et al.
Published: (2025-03-01)

Serum manganese and its association with non-alcoholic fatty liver disease: findings from NHANES
by: Zipeng He, et al.
Published: (2025-03-01)

Association between oxidative stress and liver fibrosis severity in non-alcoholic fatty liver disease: insights from the pro-oxidant antioxidant balance method in a population from Tehran and Mashhad, Iran
by: Hami Ashraf, et al.
Published: (2025-03-01)

Increased risk of vascular complications in patients with type 2 diabetes and fatty liver disease
by: Weixia Sun, et al.
Published: (2024-11-01)

Clinical Significance of Serum Bile Acid Profiles in Fatty Liver
by: Sun HY, et al.
Published: (2024-12-01)

The effect of empagliflozin on non-alcoholic fatty liver disease-related parameters in patients with type 2 diabetes mellitus: a randomized controlled trial
by: Fatemeh Shojaei, et al.
Published: (2025-02-01)

Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study
by: Kimiko Sakai, et al.
Published: (2024-12-01)

Transient elastography, ultrasound imaging and liver enzymes in diagnosis of cystic fibrosis-related liver disease in children
by: Yu.G. Tsyunchyk, et al.
Published: (2024-09-01)

Two-Dimensional Shear-Wave Elastography: Accuracy in Liver Fibrosis Staging Using Magnetic Resonance Elastography as the Reference Standard
by: Puwitch Charoenchue, et al.
Published: (2024-12-01)

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study
by: Damien Denimal, et al.
Published: (2025-04-01)

Vibration-controlled transient elastography in shaping the epidemiology and management of steatotic liver disease: Editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023”
by: Xiao-Dong Zhou, et al.
Published: (2025-04-01)

Non-invasive screening for liver fibrosis by acoustic radiation force impulse in patients with ciliopathies
by: Johanna Bresch, et al.
Published: (2025-04-01)

Evaluation of liver fibrosis in HCV-infected patients using two-dimensional shear-wave elastography (2D-SWE) before and after antiviral treatment
by: Inglot Marcin, et al.
Published: (2024-12-01)

Meta-analysis of the clinical efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
by: Yuan-Yuan Xu, et al.
Published: (2024-09-01)

Hepatogenic weakness as a clinical marker of hyperammonemia and of the effectiveness of its correction in patients with pre-cirrhotic stages of non-alcoholic fatty liver disease
by: E. M. Petrova, et al.
Published: (2021-06-01)

Correlation of Liver Fibrosis using Noninvasive Transient Elastography with Histological Staging in Infants with Cholestasis - A Prospective Analytical Study
by: Deepti Naik, et al.
Published: (2025-03-01)

Redefining Liver Fibrosis Risk Assessment in Indians with Type 2 Diabetes: New FIB-4 Score Cutoff for Optimizing Sequential Assessment with Transient Elastography
by: Rajat Deb, et al.
Published: (2025-03-01)

The level of plasma homocysteine in patients with non-alcoholic fatty liver disease in combination with type 2 diabetes
by: V. F. Orlovskiy, et al.
Published: (2015-06-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

Doppler ultrasound and 2D shear wave ultrasound elastography for liver fibrosis evaluation in Fontan-associated liver disease
by: Nakarin Inmutto, et al.
Published: (2025-08-01)

HES V2.0 surpasses GALAD for HCC detection: a review of multi-dimensional biomarker scores and studies
by: Fouad Jaber, et al.
Published: (2025-12-01)